Competition between cancer cells and T cells under immunotherapy: a structured population approach
T cells are key players in the immune action against the invasion of cancer cells. During an immune response, antigen-specific T cells dynamically sculpt the antigenic distribution of cancer cells, and cancer cells concurrently shape the repertoire of antigen-specific T cells. The succession of thes...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2015-01-01
|
Series: | ITM Web of Conferences |
Online Access: | http://dx.doi.org/10.1051/itmconf/20150500005 |
id |
doaj-9d1ec3305417465b88ca3443d0cfb715 |
---|---|
record_format |
Article |
spelling |
doaj-9d1ec3305417465b88ca3443d0cfb7152021-04-02T15:31:04ZengEDP SciencesITM Web of Conferences2271-20972015-01-0150000510.1051/itmconf/20150500005itmconf_mod2015_00005Competition between cancer cells and T cells under immunotherapy: a structured population approachDelitala Marcello0Lorenzi Tommaso1Melensi Matteo2Department of Mathematical Sciences, Politecnico di TorinoCentre de Mathématiques et de Leurs Applications, ENS Cachan, Cachan Cedex, France & INRIA-Paris-Rocquencourt, MAMBA TeamDepartment of Health Sciences, A. Avogadro Università del Piemonte OrientaleT cells are key players in the immune action against the invasion of cancer cells. During an immune response, antigen-specific T cells dynamically sculpt the antigenic distribution of cancer cells, and cancer cells concurrently shape the repertoire of antigen-specific T cells. The succession of these reciprocal selective sweeps can result in “chase-and-escape” dynamics, and lead to immune evasion. It has been proposed that immune evasion can be countered by immunotherapy strategies aimed at regulating the immune response. In this work, we present a mathematical model of the competition between cancer cells and T cells under immunotherapy. We show that effective immunotherapy protocols can be designed by using therapeutic agents that boost T-cell proliferation in combination with boosters of immune memory.http://dx.doi.org/10.1051/itmconf/20150500005 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Delitala Marcello Lorenzi Tommaso Melensi Matteo |
spellingShingle |
Delitala Marcello Lorenzi Tommaso Melensi Matteo Competition between cancer cells and T cells under immunotherapy: a structured population approach ITM Web of Conferences |
author_facet |
Delitala Marcello Lorenzi Tommaso Melensi Matteo |
author_sort |
Delitala Marcello |
title |
Competition between cancer cells and T cells under immunotherapy: a structured population approach |
title_short |
Competition between cancer cells and T cells under immunotherapy: a structured population approach |
title_full |
Competition between cancer cells and T cells under immunotherapy: a structured population approach |
title_fullStr |
Competition between cancer cells and T cells under immunotherapy: a structured population approach |
title_full_unstemmed |
Competition between cancer cells and T cells under immunotherapy: a structured population approach |
title_sort |
competition between cancer cells and t cells under immunotherapy: a structured population approach |
publisher |
EDP Sciences |
series |
ITM Web of Conferences |
issn |
2271-2097 |
publishDate |
2015-01-01 |
description |
T cells are key players in the immune action against the invasion of cancer cells. During an immune response, antigen-specific T cells dynamically sculpt the antigenic distribution of cancer cells, and cancer cells concurrently shape the repertoire of antigen-specific T cells. The succession of these reciprocal selective sweeps can result in “chase-and-escape” dynamics, and lead to immune evasion. It has been proposed that immune evasion can be countered by immunotherapy strategies aimed at regulating the immune response. In this work, we present a mathematical model of the competition between cancer cells and T cells under immunotherapy. We show that effective immunotherapy protocols can be designed by using therapeutic agents that boost T-cell proliferation in combination with boosters of immune memory. |
url |
http://dx.doi.org/10.1051/itmconf/20150500005 |
work_keys_str_mv |
AT delitalamarcello competitionbetweencancercellsandtcellsunderimmunotherapyastructuredpopulationapproach AT lorenzitommaso competitionbetweencancercellsandtcellsunderimmunotherapyastructuredpopulationapproach AT melensimatteo competitionbetweencancercellsandtcellsunderimmunotherapyastructuredpopulationapproach |
_version_ |
1721559911306887168 |